Everand Logo

Welcome to Everand!

  • Discover this podcast and so much more

    Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

    Are We Ready for Biosimilars in Multiple Sclerosis? Experts Discuss Lessons From Other Immune-Mediated Diseases

    Are We Ready for Biosimilars in Multiple Sclerosis? Experts Discuss Lessons From Other Immune-Mediated Diseases

    FromKeeping Current

    Start listeningView podcast show

    Are We Ready for Biosimilars in Multiple Sclerosis? Experts Discuss Lessons From Other Immune-Mediated Diseases

    FromKeeping Current

    ratings:
    Length:
    35 minutes
    Released:
    Mar 29, 2023
    Format:
    Podcast episode

    Description

    What is the clinical use of biosimilars and how to best communicate with patients to avoid the nocebo effect?  Credit available for this activity expires: 3/29/24 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/990193?ecd=bdc_podcast_libsyn_mscpedu
    Released:
    Mar 29, 2023
    Format:
    Podcast episode

    Titles in the series (99)

    Experts discuss relevant and actionable strategies for practice improvement as well as timely clinical topics.